Published in Nature on December 16, 2009
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer | NCT02963090
Metabolism of Deuterated NNN in Smokeless Tobacco Users | NCT02414477
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
International network of cancer genome projects. Nature (2010) 20.35
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72
The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
The life history of 21 breast cancers. Cell (2012) 10.59
Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet (2010) 10.15
The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature (2010) 10.04
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol (2011) 9.60
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics (2011) 8.19
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature (2012) 7.76
Sequence analysis of mutations and translocations across breast cancer subtypes. Nature (2012) 7.76
Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A (2010) 7.70
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63
SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (2011) 5.62
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet (2012) 4.82
DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics (2012) 4.79
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med (2011) 4.37
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature (2012) 3.92
The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res (2012) 3.80
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80
Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell (2011) 3.65
Deciphering signatures of mutational processes operative in human cancer. Cell Rep (2013) 3.61
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A (2011) 3.54
Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 3.25
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics (2012) 3.21
Clinical implications of the cancer genome. J Clin Oncol (2010) 3.11
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet (2011) 3.10
Variation in the mutation rate across mammalian genomes. Nat Rev Genet (2011) 3.09
Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature (2016) 3.05
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet (2012) 3.03
Making sense of cancer genomic data. Genes Dev (2011) 3.01
Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer (2011) 2.77
A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data. Genome Biol (2010) 2.72
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol (2013) 2.59
Revisiting Mendelian disorders through exome sequencing. Hum Genet (2011) 2.57
NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene (2010) 2.56
Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50
ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell (2010) 2.50
Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov (2011) 2.49
Challenges of sequencing human genomes. Brief Bioinform (2010) 2.39
Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet (2010) 2.39
Personal genome sequencing: current approaches and challenges. Genes Dev (2010) 2.38
Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell (2012) 2.37
Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature (2015) 2.35
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30
Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev (2011) 2.29
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A (2013) 2.23
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res (2012) 2.19
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer (2010) 2.11
Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol (2011) 2.10
Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One (2010) 2.10
Lung carcinogenesis by tobacco smoke. Int J Cancer (2012) 2.06
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell (2013) 2.00
Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A (2011) 1.98
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res (2012) 1.95
Estimation of rearrangement phylogeny for cancer genomes. Genome Res (2011) 1.91
Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res (2011) 1.90
The molecular pathology of cancer. Nat Rev Clin Oncol (2010) 1.86
Error-prone translesion synthesis mediates acquired chemoresistance. Proc Natl Acad Sci U S A (2010) 1.85
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis (2012) 1.84
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell (2014) 1.84
High-throughput discovery of rare insertions and deletions in large cohorts. Genome Res (2010) 1.83
The cancer antigenome. EMBO J (2012) 1.78
Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74
SeqWare Query Engine: storing and searching sequence data in the cloud. BMC Bioinformatics (2010) 1.72
An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res (2012) 1.71
DNA replication fidelity and cancer. Semin Cancer Biol (2010) 1.69
The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J Thorac Oncol (2015) 1.68
The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell (2013) 1.68
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. J Pathol (2012) 1.67
Molecular biology of lung cancer. J Thorac Dis (2013) 1.67
Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67
Genome-wide patterns and properties of de novo mutations in humans. Nat Genet (2015) 1.65
Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods (2013) 1.64
That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer (2012) 1.63
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev (2013) 1.62
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J (2014) 1.59
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Circos: an information aesthetic for comparative genomics. Genome Res (2009) 40.02
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
The cancer genome. Nature (2009) 23.13
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics (2007) 14.25
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene (2002) 7.04
Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell (2009) 5.41
Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell (2009) 5.05
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
CHD5 is a tumor suppressor at human 1p36. Cell (2007) 4.90
A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res (2006) 4.32
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06
Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer (2009) 3.14
Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res (2008) 3.06
Molecular genetics of small cell lung carcinoma. Semin Oncol (2001) 3.02
Small cell lung cancer. Mayo Clin Proc (2008) 2.99
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res (2007) 2.94
Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res (2004) 2.75
Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci U S A (2006) 2.74
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res (2009) 2.31
Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol (2007) 2.30
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes Chromosomes Cancer (2004) 2.22
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene (1998) 1.98
The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol (2007) 1.89
Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst (1984) 1.84
Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol (2007) 1.80
Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A (1997) 1.69
Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene (1990) 1.63
The changing epidemiology of lung cancer. Methods Mol Biol (2009) 1.55
Cigarette smoking and histologic type of lung cancer in men. Chest (1997) 1.53
Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci (2006) 1.43
Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosomes Cancer (1994) 1.40
Interactions of human replication protein A with single-stranded DNA adducts. Biochem J (2005) 1.35
Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol (2005) 1.35
Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res (2008) 151.16
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
The Bioperl toolkit: Perl modules for the life sciences. Genome Res (2002) 58.63
The Pfam protein families database. Nucleic Acids Res (2002) 51.34
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Whole-genome sequencing and variant discovery in C. elegans. Nat Methods (2008) 31.92
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods (2008) 31.04
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics (2005) 24.54
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
The cancer genome. Nature (2009) 23.13
A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol (2008) 21.72
Signatures of mutational processes in human cancer. Nature (2013) 21.63
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
An integrated semiconductor device enabling non-optical genome sequencing. Nature (2011) 20.85
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
International network of cancer genome projects. Nature (2010) 20.35
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (2005) 18.59
EnsMart: a generic system for fast and flexible access to biological data. Genome Res (2004) 17.64
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72